Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19

BACKGROUND AND OBJECTIVE: The risk of thrombotic complications in critical patients with COVID-19 remains extremely high, and multicenter trials failed to prove a survival benefit of escalated doses of low-molecular-weight heparins (nadroparin calcium) in this group. The aim of this study was to dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Piwowarczyk, Paweł, Szczukocka, Marta, Cios, Wojciech, Okuńska, Paulina, Raszewski, Grzegorz, Borys, Michał, Wiczling, Paweł, Czuczwar, Mirosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126531/
https://www.ncbi.nlm.nih.gov/pubmed/37097604
http://dx.doi.org/10.1007/s40262-023-01244-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126531/
https://www.ncbi.nlm.nih.gov/pubmed/37097604
http://dx.doi.org/10.1007/s40262-023-01244-4

Ejemplares similares